Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians

Atherosclerosis

Volumn 242, Issue 2, 2015, Pages 521-528

  Khalifa, Mahmoud ^a,k   Noureen, Asma ^a   Ertelthalner, Kathrin ^a   Bandegi, Ahmad Reza ^a,l   Delport, Rhena ^a,b   Firdaus, Wance J J ^a,m   Geethanjali, Finney S ^a,c   Luthra, Kalpana ^a,d   Makemaharn, Orawan ^a,e   Pang, Richard W C ^a,f   Salem, Abdel Halim ^a,n   Sasaki, Jun ^g   Schiefenhoevel, Wulf ^h   Lingenhel, Arno ^a   Kronenberg, Florian ^a   Utermann, Gerd ^a   Schmidt, Konrad ^a,i,j  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e MAHIDOL UNIVERSITY   (Thailand)

^f QUEEN MARY HOSPITAL   (Hong Kong)

^g INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^h MAX PLANCK INSTITUTE FOR ORNITHOLOGY   (Germany)

ⁱ ALBERT SCHWEITZER HOSPITAL   (Gabon)

^j UNIVERSITY OF TÜBINGEN   (Germany)

^k Al Azhar University   (Egypt)

^l SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^m JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ ARABIAN GULF UNIVERSITY   (Bahrain)

more..

Author keywords

Copy number variation; Coronary artery disease; Genetic variation; Lipoprotein(a); Population genetics

Indexed keywords

LIPOPROTEIN A; APOLIPOPROTEIN A; GENETIC MARKER; ISOPROTEIN;

AFRICA; APOLIPOPROTEIN A GENE; ARTICLE; ASIA; CHINESE; CONTROLLED STUDY; COPY NUMBER VARIATION; CORONARY ARTERY DISEASE; EAST ASIAN; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIAN; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNOLOGY; GENETIC MARKER; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PHYLOGENY;

AFRICA; ALLELES; APOLIPOPROTEINS A; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CORONARY ARTERY DISEASE; DNA COPY NUMBER VARIATIONS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE FREQUENCY; GENETIC MARKERS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS;

EID: 84939781100     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.07.015     Document Type: Article

References (50)

1. Kronenberg F., Utermann G. Lipoprotein(a): resurrected by genetics. J. Intern Med. 2013 January, 273(1):6-30.
2. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., Scanu A.M., Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987 November 12, 330(6144):132-137.
3. Haibach C., Kraft H.G., Kochl S., Abe A., Utermann G. The number of kringle IV repeats 3-10 is invariable in the human apo(a) gene. Gene 1998 February 27, 208(2):253-258.
4. Kraft H.G., Kochl S., Menzel H.J., Sandholzer C., Utermann G. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum. Genet. 1992 November, 90(3):220-230.
5. Lackner C., Boerwinkle E., Leffert C.C., Rahmig T., Hobbs H.H. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 1991 June, 87(6):2153-2161.
6. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 1987 August, 80(2):458-465.
7. Mooser V., Mancini F.P., Bopp S., Petho-Schramm A., Guerra R., Boerwinkle E., Muller H.J., Hobbs H.H. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum. Mol. Genet. 1995 February, 4(2):173-181.
8. Trommsdorff M., Kochl S., Lingenhel A., Kronenberg F., Delport R., Vermaak H., Lemming L., Klausen I.C., Faergeman O., Utermann G. A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J. Clin. Invest. 1995 July, 96(1):150-157.
9. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J. Clin. Invest. 1992 July, 90(1):52-60.
10. Chen T.J., Ji C.Y., Hu Y.H. Genetic and environmental influences on serum lipids and the effects of puberty: a Chinese twin study. Acta Paediatr. 2009 June, 98(6):1029-1036.
11. Rao V.S., Khadrinarasimhaih N.B., Kanjilal S., Mukerjee M., Kakkar V.V. Genetic contribution to variation in atherothrombotic phenotypes in the Asian Indian population. The Indian Atherosclerosis Research Study. Thromb. Haemost. 2009 August, 102(2):379-388.
12. White A.L., Hixson J.E., Rainwater D.L., Lanford R.E. Molecular basis for "null" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon. J. Biol. Chem. 1994 March 25, 269(12):9060-9066.
13. Brunner C., Lobentanz E.M., Petho-Schramm A., Ernst A., Kang C., Dieplinger H., Muller H.J., Utermann G. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J. Biol. Chem. 1996 December 13, 271(50):32403-32410.
14. Perombelon Y.F., Soutar A.K., Knight B.L. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J. Clin. Invest. 1994 April, 93(4):1481-1492.
15. Gaw A., Boerwinkle E., Cohen J.C., Hobbs H.H. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J. Clin. Invest. 1994 June, 93(6):2526-2534.
16. Kraft H.G., Lingenhel A., Pang R.W., Delport R., Trommsdorff M., Vermaak H., Janus E.D., Utermann G. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur. J. Hum. Genet. 1996, 4(2):74-87.
17. Zysow B.R., Lindahl G.E., Wade D.P., Knight B.L., Lawn R.M. C/T polymorphism in the 5' untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler. Thromb. Vasc. Biol. 1995 January, 15(1):58-64.
18. Ogorelkova M., Gruber A., Utermann G. Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians. Hum. Mol. Genet. 1999 October, 8(11):2087-2096.
19. Parson W., Kraft H.G., Niederstatter H., Lingenhel A.W., Kochl S., Fresser F., Utermann G. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a). Hum. Mutat. 2004 December, 24(6):474-480.
20. Erqou S., Thompson A., Di Angelantonio E., Saleheen D., Kaptoge S., Marcovina S., Danesh J. Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J. Am. Coll. Cardiol. 2010 May 11, 55(19):2160-2167.
21. Luke M.M., Kane J.P., Liu D.M., Rowland C.M., Shiffman D., Cassano J., Catanese J.J., Pullinger C.R., Leong D.U., Arellano A.R., Tong C.H., Movsesyan I., Naya-Vigne J., Noordhof C., Feric N.T., Malloy M.J., Topol E.J., Koschinsky M.L., Devlin J.J., Ellis S.G. A polymorphism in the protease-like domain of Apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2007 September, 27(9):2030-2036. Epub 2007 Jun 14.
22. Shiffman D., O'Meara E.S., Bare L.A., Rowland C.M., Louie J.Z., Arellano A.R., Lumley T., Rice K., Iakoubova O., Luke M.M., Young B.A., Malloy M.J., Kane J.P., Ellis S.G., Tracy R.P., Devlin J.J., Psaty B.M. Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 2008 January, 28(1):173-179.
23. Clarke R., Peden J.F., Hopewell J.C., Kyriakou T., Goel A., Heath S.C., Parish S., Barlera S., Franzosi M.G., Rust S., Bennett D., Silveira A., Malarstig A., Green F.R., Lathrop M., Gigante B., Leander K., de Faire U., Seedorf U., Hamsten A., Collins R., Watkins H., Farrall M. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 2009 December 24, 361(26):2518-2528.
24. Leebmann J., Roeseler E., Julius U., Heigl F., Spitthoever R., Heutling D., Breitenberger P., Maerz W., Lehmacher W., Heibges A., Klingel R. Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study. Circulation 2013 December 17, 128(24):2567-2576.
25. Kraft H.G., Lingenhel A., Bader G., Kostner G.M., Utermann G. The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1996 August 23, 125(1):53-61.
26. Kronenberg F. Genetic determination of lipoprotein(a) and its association with cardiovascular disease: convenient does not always mean better. J. Intern Med. 2014 September, 276(3):243-247.
27. Shiffman D., Slawsky K., Fusfeld L., Devlin J.J., Goss T.F. Cost-effectiveness model of use of genetic testing as an aid in assessing the likely benefit of aspirin therapy for primary prevention of cardiovascular disease. Clin. Ther. 2012 June, 34(6):1387-1394.
28. Arai K., Luke M.M., Koschinsky M.L., Miller E.R., Pullinger C.R., Witztum J.L., Kane J.P., Tsimikas S. The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles. Atherosclerosis 2010 April, 209(2):498-503.
29. Takeuchi F., Yokota M., Yamamoto K., Nakashima E., Katsuya T., Asano H., Isono M., Nabika T., Sugiyama T., Fujioka A., Awata N., Ohnaka K., Nakatochi M., Kitajima H., Rakugi H., Nakamura J., Ohkubo T., Imai Y., Shimamoto K., Yamori Y., Yamaguchi S., Kobayashi S., Takayanagi R., Ogihara T., Kato N. Genome-wide association study of coronary artery disease in the Japanese. Eur. J. Hum. Genet. 2012 March, 20(3):333-340.
30. Scholz M., Kraft H.G., Lingenhel A., Delport R., Vorster E.H., Bickeboller H., Utermann G. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur. J. Hum. Genet. 1999 February, 7(2):169-178.
31. Geethanjali F.S., Luthra K., Lingenhel A., Kanagasaba-Pathy A.S., Jacob J., Srivastava L.M., Vasisht S., Kraft H.G., Utermann G. Analysis of the apo(a) size polymorphism in Asian Indian populations: association with Lp(a) concentration and coronary heart disease. Atherosclerosis 2003 July, 169(1):121-130.
32. Schmidt K., Kraft H.G., Parson W., Utermann G. Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon. Eur. J. Hum. Genet. 2006 February, 14(2):190-201.
33. Erdel M., Hubalek M., Lingenhel A., Kofler K., Duba H.C., Utermann G. Counting the repetitive kringle-IV repeats in the gene encoding human apolipoprotein(a) by fibre-FISH. Nat. Genet. 1999 April, 21(4):357-358.
34. Kronenberg F., Lobentanz E.M., Konig P., Utermann G., Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J. Lipid Res. 1994 July, 35(7):1318-1328.
35. Gaunt T.R., Rodriguez S., Zapata C., Day I.N. MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinf. 2006 April 27, 7:227.
36. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 January 15, 21(2):263-265.
37. Rowland C.M., Pullinger C.R., Luke M.M., Shiffman D., Green L., Movsesyan I., Devlin J.J., Malloy M.J., Kane J.P., Undas A. Lipoprotein (a), LPA Ile4399Met, and fibrin clot properties. Thromb. Res. 2014 May, 133(5):863-867.
38. Li Z.G., Li G., Zhou Y.L., Chen Z.J., Yang J.Q., Zhang Y., Sun S., Zhong S.L. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention. Lipids Health Dis. 2013 August 27, 12:127. 127-212. 10.1186/1476-511X-12-127.
39. Noureen A., Fresser F., Utermann G., Schmidt K. Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations. PLoS One 2015, 10(3):e0121582.
40. Sandholzer C., Boerwinkle E., Saha N., Tong M.C., Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J. Clin. Invest. 1992 March, 89(3):1040-1046.
41. Qin S., Wang S., Li C. Apolipoprotein (a) polymorphism in relation to coronary heart disease in Chinese Han nationality. Zhonghua Yi Xue Za Zhi 1995 October, 75(10):588.
42. Banerjee D., Wong E.C., Shin J., Fortmann S.P., Palaniappan L. Racial and ethnic variation in lipoprotein (a) levels among Asian Indian and Chinese patients. J. Lipids 2011, 2011:291954. Epub 2011 May 23.:291954. 10.1155/2011/291954.
43. Anderson J.L., Knight S., May H.T., Horne B.D., Bair T.L., Huntinghouse J.A., Rollo J.S., Muhlestein J.B., Carlquist J.F. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease. Am. J. Cardiol. 2013 September 15, 112(6):799-804.
44. Chasman D.I., Shiffman D., Zee R.Y., Louie J.Z., Luke M.M., Rowland C.M., Catanese J.J., Buring J.E., Devlin J.J., Ridker P.M. Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 2009 April, 203(2):371-376.
45. Sandholzer C., Saha N., Kark J.D., Rees A., Jaross W., Dieplinger H., Hoppichler F., Boerwinkle E., Utermann G. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler. Thromb. 1992 October, 12(10):1214-1226.
46. Hoogeveen R.C., Gambhir J.K., Gambhir D.S., Kimball K.T., Ghazzaly K., Gaubatz J.W., Vaduganathan M., Rao R.S., Koschinsky M., Morrisett J.D. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J. Lipid Res. 2001 April, 42(4):631-638.
47. Gambhir J.K., Kaur H., Prabhu K.M., Morrisett J.D., Gambhir D.S. Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians. Clin. Biochem. 2008 May, 41(7-8):453-458. Epub 2008 Feb 5.
48. The Coronary Artery Disease (C4D) Genetics Consortium A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet. 2011 March 6, 43(4):339-344.
49. Tsimikas S., Clopton P., Brilakis E.S., Marcovina S.M., Khera A., Miller E.R., de Lemos J.A., Witztum J.L. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation 2009 April 7, 119(13):1711-1719.
50. Keinan A., Mullikin J.C., Patterson N., Reich D. Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans. Nat. Genet. 2007 October, 39(10):1251-1255.